LISAvienna: March newsletter available now

Ten times a year, the LISAvienna newsletter keeps you updated on news from the Vienna based life sciences community as well as on funding opportunities and events.

This time our news review includes success stories from Arsanis, Eucodis, Evercyte, mySugr, Piur Imaging, Scarletred, TAmiRNA, Technoclone and Viravaxx. In addition, we draw your attention to some academic publications that hit the headlines recently.

Furthermore, we highlight relevant events in Vienna and international trade fairs and partnering meetings in our newsletter. Up-to-date information on funding opportunities and links to the spring edition of our biannual Highlights publication and to the registration form for our business meeting on medical devices on March 29 are also included.

Read the March newsletter online here >>

Free registration >>

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)